Skip to main content

CAROLINA Project

Ovarian rejuvenation by partial cellular reprogramming

Description

The CAROLINA Project aims to gain an in-depth understanding of the biological mechanisms of ovarian aging and to develop innovative strategies to delay or prevent the age-related decline in reproductive function. This approach could pave the way for new therapies targeting age-related infertility and generate fundamental knowledge about the cellular, molecular, and epigenetic changes that characterize reproductive aging.

At its core, the project focuses on developing and optimizing partial cellular reprogramming in ovarian tissue and assessing its effects on gonadal function. Cellular reprogramming involves converting terminally differentiated somatic cells into pluripotent cells through the controlled expression of defined reprogramming factors. When applied in a partial and transient manner, this process can reverse cellular aging phenotypes without completely erasing the cell’s original identity, thereby preserving its specific functionality.

Read more

Description

The CAROLINA Project aims to gain an in-depth understanding of the biological mechanisms of ovarian aging and to develop innovative strategies to delay or prevent the age-related decline in reproductive function. This approach could pave the way for new therapies targeting age-related infertility and generate fundamental knowledge about the cellular, molecular, and epigenetic changes that characterize reproductive aging.

At its core, the project focuses on developing and optimizing partial cellular reprogramming in ovarian tissue and assessing its effects on gonadal function. Cellular reprogramming involves converting terminally differentiated somatic cells into pluripotent cells through the controlled expression of defined reprogramming factors. When applied in a partial and transient manner, this process can reverse cellular aging phenotypes without completely erasing the cell’s original identity, thereby preserving its specific functionality.

Read more

Team members

Felipe Vilella, Ph.D.

Vice-President and Senior Principal Investigator

Felipe Vilella, a Ph.D. in molecular biology, is the consolidated group leader of the Maternal Fetal Crosstalk Laboratory at INCLIVA/Carlos Simon Foundation. He performed two post-doctoral positions, one in the Clinical Science Centre of the MRC in London (UK) and the other in the Centro de Investigaciones Principe Felipe in Valencia (Spain). He was a visiting researcher for five years at Stanford University (USA) and two years at Harvard University (USA).

His main scientific interest focuses on understanding the communication mechanisms occurring between the mother and the embryo and elucidating how the mother can genetically modify the preimplantation embryo.

His research was the first to demonstrate the transmission of genetic information from the mother to the preimplantation embryo, demonstrating that the mother can modify the embryo transcriptomically and/or epigenetically, regardless of its genetic background (PMID: 26395145). He studied the effect of microRNAs and mitochondrial DNA secreted by endometrial cells on the embryo (PMID: 31665361, 29390102). He also focuses on understanding the implantation process, elucidating how endometrial cells communicate with each other at the single-cell level (PMID: 32929266).

He has published 42 papers in peer-reviewed journals with an accumulated impact factor of 399.35. His papers have been cited 2,267 times with an average of 56.68 citations/paper. He has an H-Index of 21, has published 12 book chapters, and has directed 6 Ph.D. theses. He has participated in over 16 international projects, being an independent principal investigator in 11. He has participated as an invited speaker at over 80 international conferences.

ResearchID: C-2970-2018. http://www.researcherid.com/rid/C-2970-2018

Ana Monteagudo, Ph.D.

Postdoctoral Researcher

Alexandra Soto

Predoctoral Researcher